Raphael Pharmaceutical Inc. (RAPH): 8-K filed Mar 24, 2026

Form type

8-K

Filing date

Mar 24, 2026

Accession number

0001213900-26-033507

Filer

Raphael Pharmaceutical Inc. (CIK 1415397)